In "Canada's Federal Court of Appeal Offers Some Guidance on Transfer Pricing Issues," written by Julius Melnitzer for InsideCounsel, Claire Kennedy discusses the Federal Court of Appeal's decision in GlaxoSmithKline v. The Queen. According to Claire, the decision "established a sensible principle" for determining appropriate transfer pricing.
In The News
Claire Kennedy Discusses Transfer Pricing in InsideCounsel
October 1, 2010
Republishing Requests
For permission to republish this or any other publication, contact Amrita Kochhar at kochhara@bennettjones.com.
For informational purposes only
This publication provides an overview of legal trends and updates for informational purposes only. For personalized legal advice, please contact the authors.
Latest Insights
See All Insights
Blog
Kees de Ridder, Benjamin K. Reingold & Stephen D. Burns
Supreme Court to Assess Subject Matter Eligibility in Canadian Patent Law: Implications Beyond the Pharmaceutical Context
October 9, 2025
Blog
Benjamin K. Reingold & Stephen D. Burns
The Implications of AI on Performance Marketing
October 9, 2025Blog
Sean Zweig, Andrew Froh & James Atkinson
Trend Watch: Determining COMI in US Chapter 15 Proceedings
October 8, 2025
